Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)DivestmentsDividends Paid - CommonFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Select Medical Holdings (SEM) Other Working Capital Changes (2018 - 2025)

Select Medical Holdings (SEM) has disclosed Other Working Capital Changes for 7 consecutive years, with -$7.9 million as the latest value for Q4 2025.

  • On a quarterly basis, Other Working Capital Changes rose 22.56% to -$7.9 million in Q4 2025 year-over-year; TTM through Dec 2025 was -$413000.0, a 97.71% increase, with the full-year FY2025 number at -$413000.0, up 97.71% from a year prior.
  • Other Working Capital Changes was -$7.9 million for Q4 2025 at Select Medical Holdings, down from $8.1 million in the prior quarter.
  • In the past five years, Other Working Capital Changes ranged from a high of $12.2 million in Q1 2025 to a low of -$16.2 million in Q2 2024.
  • A 5-year average of $908650.0 and a median of $1.2 million in 2021 define the central range for Other Working Capital Changes.
  • Peak YoY movement for Other Working Capital Changes: skyrocketed 16488.89% in 2021, then crashed 1959.22% in 2023.
  • Select Medical Holdings' Other Working Capital Changes stood at $596000.0 in 2021, then surged by 1206.88% to $7.8 million in 2022, then surged by 55.32% to $12.1 million in 2023, then crashed by 184.44% to -$10.2 million in 2024, then grew by 22.56% to -$7.9 million in 2025.
  • Per Business Quant, the three most recent readings for SEM's Other Working Capital Changes are -$7.9 million (Q4 2025), $8.1 million (Q3 2025), and -$12.8 million (Q2 2025).